Trial Number
921-19
Condition
Germ Cell Cancer
Participant Age Range
11 years to 45 years
Participant Gender
Any
Enrolling Participants
Yes
Overview
“AGCT1532: Phase 3 Accelerated BEP Trial: A Randomised Phase 3 Trial of Accelerated versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-risk Metastatic Germ Cell Tumours”
A Randomized Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-risk Metastatic Germ Cell Tumours Conditions.